Insider Cluster (2 insiders) ·Filed Aug 7, 2026

MRK

Merck & Co., Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 2 insiders, $1.4M total
Actionable Insight • Neutral

This insider cluster is routine post-earnings option exercise and sell-to-cover activity by two EVPs. At 0.0004% of market cap, it carries no material signal. Monitor for any C-suite open-market sales or purchases in the coming weeks, but this filing alone does not warrant a trading action.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
MRK ▲ +17.24% at T+20d
NEUTRAL call ✓ call won +17.24% · α vs SPY +17.63% · entry $128.23 → $150.33
Next anchor: T+60d in 28d
Latest observation: T+37 +9.87% FF3 residual α
Entry anchored
Aug 6, 06:33 PM ET
via 1-min bar
T+1d
+2.08%
call +2.08% · α +2.11%
$130.90
settled 8w ago
T+5d
+5.93%
call +5.93% · α +5.53%
$135.83
settled 7w ago
T+20d
+17.24%
call +17.24% · α +17.63%
$150.33
settled 29d ago
T+60d
—
call — · α —
—
in 28d

Price Chart

Loading chart...

Executive Summary

Two EVPs at Merck (Williams and Maraldo) executed open-market sales totaling ~$1.4M on August 5, 2026, one day after the company reported Q2 earnings that beat consensus on revenue and EPS. The sales are part of a larger cluster of option exercises and same-day share disposals, consistent with routine post-vesting tax and liquidity management. At $317B market cap, the $1.4M represents ~0.0004% of market cap — trivial and non-informative. The historical calibration shows a 25% win rate on prior MRK reports, but this cluster is too small to move the stock.

Key Financial Metrics

Direction
selling
Total Value
$1.4M
Insiders
2

Key Facts

  • Two EVPs sold a combined ~$1.4M in open-market transactions on Aug 5, 2026
  • Sales occurred one day after Merck's Q2 2026 earnings beat (revenue $16.6B, +5% YoY, consensus $16.37B)
  • Total open-market sales represent ~0.0004% of Merck's $317B market cap — immaterial
  • Both sales were part of larger option exercise-and-sell patterns, consistent with routine post-vesting tax withholding and diversification
  • No C-suite (CEO/CFO) participation; no open-market purchases in the cluster

Financial Impact

Open-market sales of ~$1.4M, representing ~0.0004% of market cap — trivial

dilution

Risk Factors

  • Insider sales may continue as other executives exercise options post-earnings
  • No bearish signal from this cluster — risk of over-interpreting routine activity

Market Snapshot

Price
$128.57
Volume
116
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
69% bullish (36 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MRK-1786169751573
20 reports for MRK
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+20▲ +18.67%Aug 6, 2026
Filters
Rows
Reports for MRK — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
Court Ruling
NEUTRAL ★ 1/10
$143.93 $146.87▲ +2.04%▲ +2.26%$143.81 (−0.08%)
Sep 9, 2026
23d ago
Court Ruling
NEUTRAL ★ 1/10
$147.53 $144.91▼ −1.78%▼ −1.12%$143.81 (−2.52%)
Aug 27, 2026
5w ago
Court Ruling
NEUTRAL ★ 1/10
$149.54 $152.34▲ +1.87%▲ +1.60%$143.81 (−3.83%)
Aug 24, 2026
5w ago
Court Ruling
BEARISH ★ 5/10
$150.66 $147.73▲ +1.95%▲ +2.42%$143.81 (+4.55%)
Aug 20, 2026
6w ago
ANALYST-UPGRADE
MIXED ★ 5/10
$148.99 $149.54▲ +0.37%▼ −0.75%$143.81 (−3.48%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.84 $152.55▲ +12.30%▲ +13.67%$143.81 (+5.87%)
Aug 13, 2026
7w ago
Court Ruling
NEUTRAL ★ 3/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.81 (+6.09%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.81 (+6.09%)
Aug 12, 2026
7w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.81 (+8.19%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.81 (+8.19%)
Showing 10 of 20

US Market Status

Market Open — Closes in 6h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 8, 2026